Search Keyword:


Search option:


IID50435
UniprotP30680
ProteinSomatostatin receptor type 2
GeneSstr2
OrganismRattus norvegicus
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
369
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 364-369 Hetero dimer : Q9JLU4
 Evidence X-RAY 6exj B Reference
       Region 6exj B 364-369 order
 Evidence X-RAY 6exj D Reference
       Region 6exj D 364-369 order
SeqProS predicted 364-369 This region is predicted to be disordered by NeProc and AlphaFold (pLDDT < 68.5). Hetero dimer : Q9JLU4
       Region 6exj B 364-369 order
       Region 6exj D 364-369 order
 
Prediction
NeProc
Disorder 1-38,237-253,332-369
Order 39-236,254-331
ProS 7-12,18-32,237-241,248-253,359-369
AlphaFold
Disorder 1-38,239-244,333-351,358-358,361-369
Order 39-238,245-332,352-357,359-360
Function
Function in SwissProt
Receptor for somatostatin-14 and -28. This receptor is coupled via pertussis toxin sensitive G proteins to inhibition of adenylyl cyclase. In addition it stimulates phosphotyrosine phosphatase and PLC via pertussis toxin insensitive as well as sensitive G proteins. Inhibits calcium entry by suppressing voltage-dependent calcium channels. Acts as the functionally dominant somatostatin receptor in pancreatic alpha- and beta-cells where it mediates the inhibitory effect of somatostatin-14 on hormone secretion. Inhibits cell growth through enhancement of MAPK1 and MAPK2 phosphorylation and subsequent up-regulation of CDKN1B. Stimulates neuronal migration and axon outgrowth and may participate in neuron development and maturation during brain development. Mediates negative regulation of insulin receptor signaling through PTPN6. Inactivates SSTR3 receptor function following heterodimerization.